drugset / Trial / NCT01883661

Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

NCT01883661 ↗

Phase 1/2 Unknown 15 enrolled Chaitanya Hospital, Pune
NaSingle-groupOpen-labelTreatment

Summary

The aim of this study is to prove the BMMNC Therapy in Multiple sclerosis, and to control symptoms and help to maintain a normal quality of life of suffering patients.

Timeline

Start
2014-06
Primary completion
2016-11
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject BMMNC Cell therapy — Intravenous

Indications